Trends and cost structure of drug-based secondary prevention of ischemic strokes.

Neurol Res Pract · 2025 · PMC11697035 · PMID 39743621

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

a significant trendp < 0.001actually significant

There was a significant trend change in DDDs for clopidogrel in 2010 ( p < 0.001), for prasugrel in 2017 ( p < 0.001), for ASA in 2015 ( p < 0.001) and for DOACs in 2012 ( p = 0.017).

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.